Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Utsunomiya, T.
Right arrow Articles by Taguchi, K.-I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Utsunomiya, T.
Right arrow Articles by Taguchi, K.-I.
Clinical Cancer Research Vol. 6, 4965-4966, December 2000
© 2000 American Association for Cancer Research


Letter to the Editor

Correspondence re: M. Kondo et al., Increased Expression of COX-2 in Nontumor Liver Tissue Is Associated with Shorter Disease-free Survival in Patients with Hepatocellular Carcinoma. Clin. Cancer Res., 5: 4005–4012, 1999.

Tohru Utsunomiya2, Mitsuo Shimada, Tatsuya Rikimaru, Keizo Sugimachi, Ken-Ichi Ohkura, Shihoko Kaku, Koji Yamada, Kyushu University and Ken-Ichi Taguchi

Department of Surgery II, Kyushu University, Faculty of Medicine, Fukuoka 812 Japan; Department of Food Science and Technology, Kyushu University, Faculty of Agriculture, Fukuoka 812, Japan; Department of Pathology II, Faculty of Medicine, Fukuoka 812, Japan

ABSTRACT

Recently, Kondo et al. (1) reported that the level of COX1 -2 increased from normal liver to chronic hepatitis to cirrhosis. An increase in COX-2 expression in the nontumor tissues was significantly associated with relapse of HCC, which is of great interest from a clinical point of view. They suggested that the presence of active inflammation, which was highly correlated with COX-2 expression, was involved in the development of tumor relapse. On the other hand, a significant association was observed between COX-2 expression and the histological grade of HCC. Well- and moderately differentiated HCCs expressed COX-2 more strongly than poorly differentiated HCC. Taken together, these findings indicate that COX-2 may be associated with the early process of the progression of HCCs. COX-2 is a rate-limiting enzyme in the conversion of AA to prostaglandins (PGs) and other eicosanoids. AA is largely derived by biotransformation from an essential fatty acid, LA. Therefore, such a sharp fluctuation in the COX-2 enzyme activity (1) might affect the hepatic tissue fatty acid composition, especially the amounts of AA and LA. We recently determined the fatty acid composition of both HCC and nontumor tissues that had been surgically resected in the Department of Surgery II, Kyushu University. Eighteen HCC specimens with adjacent nontumor tissue, involving 10 cases of chronic viral hepatitis and 8 cases of cirrhosis, and 8 surgically resected, histologically normal liver tissue were used. Each HCC was histologically graded into one of three categories: well differentiated, moderately differentiated, and poorly differentiated, according to the criteria proposed by the Liver Cancer Study Group of Japan (2) . The hepatic tissue specimens were extracted according to the method of Folch et al. (3) . The tissue fatty acids were converted to methyl esters and analyzed by gas chromatography on a SUPELCOWAX-10 fused silica capillary column (30-m x 0.53-mm x 1.0-µm film thickness).

The content of both the LA and the AA (Fig. 1, A and BCitation , respectively) varied in a manner quite similar to that of COX-2 expression (1) . The lowest amount of AA was detected in the normal liver, and the amount of AA increased from normal liver to chronic hepatitis to cirrhosis (Fig. 1Citation B). These findings reinforce the suggestion that the amount of AA may also be associated with the early stages of hepatic carcinogenesis. On the other hand, well-differentiated HCC contained the highest LA content among the three histological grades of HCC, and the amount of LA content decreased when the HCC was graded more poorly differentiated (Fig. 1Citation A). This is the first demonstration that the tumor dedifferentiation of human HCC is correlated with the tissue fatty acid composition.



View larger version (36K):
[in this window]
[in a new window]
 
Fig. 1. The amounts of LA (A) and AA (B) in three different nontumorous hepatic tissue specimens and in three different histological grades of HCC tissue. CVH, chronic viral hepatitis; LC, liver cirrhosis; WD, well differentiated; MD, moderately differentiated; PD, poorly differentiated.

 
The reason for the increased amount of AA in chronic hepatitis and cirrhosis remains to be established. However, the increase in the AA content may aggravate the active inflammation because AA is the main substrate for the COX-2 pathway to produce proinflammatory eicosanoids. Several recent studies (4) have shown overexpression of COX-2 to be related to a poorer prognosis in cancer patients, thus suggesting that the metabolites of AA, such as PGE2, play an important role in tumorigenesis. To ameliorate the active inflammation and subsequently to inhibit tumor carcinogenesis, reductions in both the COX-2 activity and the tissue AA content seem to be desirable. Both nonsteroidal anti-inflammatory drugs and selective COX-2 inhibitors suppress inflammation, at least partially, by inhibiting the COX-2 activity. It has recently been reported that dietary fats also modulate the COX-2 expression (5 , 6) . Dietary fish oil rich in n-3 PUFAs inhibited COX-2 expression and suppressed colon tumor development in animals (5) . Furthermore, it is well known that the dietary consumption of n-3 PUFA decreases the tissue amount of AA (7) . A number of studies have demonstrated that dietary n-6 PUFA such as LA promote tumor carcinogenesis, whereas n-3 PUFAs are inhibitory. Although the number of patients included in this study was relatively small, it may be valuable to examine whether dietary n-3 PUFA or combination therapy with a pharmacological inhibition of COX-2 activity suppress inflammation and thus lead to better prognosis for patients with carcinomas such as HCC.

FOOTNOTES

1 The abbreviations used are: COX, cyclooxygenase; HCC, hepatocellular carcinoma; AA, arachidonic acid; LA, linolenic acid; PUFA, polyunsaturated fatty acid. Back

2 To whom requests for reprints should be addressed, at The Department of Surgery, Medical Institute of Bioregulation, Kyushu University, Beppu 874-0838, Japan. Phone: 81-977-27-1650; Fax: 81-977-27-1651; E-mail: tohru{at}tsurumi.beppu.kyushu-u.ac.jp Back

Received 4/18/00; revised 9/ 6/00; accepted 9/ 6/00.

REFERENCES

  1. Kondo M., Yamamoto H., Nagano H., Okami J., Ito Y., Shimizu J., Eguchi H., Miyamoto A., Dono K., Umeshita K., Matsuura N., Wakasa K., Nakamori S., Sakon M., Monden M. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma. Clin. Cancer Res., 5: 4005-4012 1999.[Abstract/Free Full Text]
  2. Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Ed. 3, pp. 34–38. Tokyo: Kanehara Shuppan, 1992.
  3. Folch J., Lees M., Sloane-Stanley G. H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226: 497-509, 1957.[Free Full Text]
  4. Sheehan K. M., Sheehan K., O’Donoghue D. P., MacSweeney F., Conroy R. M., Fitzgerald D. J., Murray F. E. The relationship between cyclooxygenase-2 expression and colorectal cancer. J. Am. Med. Assoc., 282: 1254-1257, 1999.[Abstract/Free Full Text]
  5. Singh J., Hamid R., Reddy B. S. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res., 57: 3465-3470, 1997.[Free Full Text]
  6. El-Bayoumy K., Iatropoulos M., Amin S., Hoffmann D., Wynder E. L. Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone: the impact of a high-fat diet. Cancer Res., 59: 1400-1403, 1999.[Abstract/Free Full Text]
  7. Utsunomiya T., Chavali S. R., Zhong W. W., Forse R. A. Effects of continuous tube feeding of dietary fat emulsions on eicosanoid production and on fatty acid composition during an acute septic shock in rats. Biochim. Biophys. Acta, 1214: 333-339, 1994.[Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Utsunomiya, T.
Right arrow Articles by Taguchi, K.-I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Utsunomiya, T.
Right arrow Articles by Taguchi, K.-I.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online